Concepedia

Scott A. Hammond

SA

Statistics

Publications

59

Citations

5.6K

H-Index

38

Active since

1991

Affiliations

AstraZeneca (United States)(Current)

Altimmune (United States)

University of Pittsburgh

Johns Hopkins Medicine

Johns Hopkins University

Scott A. Hammond is an author at AstraZeneca (United States) specializing in immunology, life sciences, and oncology.

ORCID

Publications per year

1991–2024

59

Publications

59

Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells

Jérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais et al. · Cancer Research · 2013 · 638 citations

, , +17

Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody

Ross Stewart, Michelle Morrow, Scott A. Hammond et al. · Cancer Immunology Research · 2015 · 409 citations

, , +17

Androgen receptor activity in T cells limits checkpoint blockade efficacy

Xiangnan Guan, Fanny Polesso, Chaojie Wang et al. · Nature · 2022 · 393 citations · Full text

, , +16

PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance

Vivek Verma, Rajeev Shrimali, Shamim Ahmad et al. · Nature Immunology · 2019 · 333 citations · Full text

, , +17

Targeting CD73 in the tumor microenvironment with MEDI9447

Carl Hay, Erin Sult, Qihui Huang et al. · OncoImmunology · 2016 · 288 citations · Full text

, , +17

1–5 of 59